KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Cash from Investing Activities (2016 - 2025)

Charles River Laboratories International (CRL) has 17 years of Cash from Investing Activities data on record, last reported at -$92.8 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 21.95% year-over-year to -$92.8 million; the TTM value through Dec 2025 reached -$209.3 million, up 14.59%, while the annual FY2025 figure was -$209.3 million, 14.59% up from the prior year.
  • Cash from Investing Activities reached -$92.8 million in Q4 2025 per CRL's latest filing, down from -$33.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $44.4 million in Q4 2022 and bottomed at -$954.2 million in Q2 2021.
  • Average Cash from Investing Activities over 5 years is -$153.2 million, with a median of -$82.7 million recorded in 2023.
  • Peak YoY movement for Cash from Investing Activities: tumbled 3233.31% in 2021, then surged 376.88% in 2022.
  • A 5-year view of Cash from Investing Activities shows it stood at $9.3 million in 2021, then soared by 376.88% to $44.4 million in 2022, then crashed by 637.08% to -$238.4 million in 2023, then soared by 68.07% to -$76.1 million in 2024, then decreased by 21.95% to -$92.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were -$92.8 million in Q4 2025, -$33.7 million in Q3 2025, and -$37.3 million in Q2 2025.